Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
ATRA logo

ATRA

NGS
Atara Biotherapeutics Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Friday 18th July 2025
9.71
+0.43 (4.63%)
Prev Close:9.28
Open:9.3
Bid:9.0
Ask:9.72
52 Week Range
5.01
18.71
Volume:54,823
Mkt Cap:55 M
Price Target
$11.17
+15.0%

Financial Statements

ATRA - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Depreciation And Amortization3 M4 M6 M9 M8 M7 M-4 M-956000.0-383000.0-48000.0
Gain On Sale Of PPE50 M
Gain On Sale Of Security50 M
Gains Loss On Disposal Of Discontinued Operations50 M
General And Administrative Expense40 M51 M72 M79 M64 M80 M70 M40 M25 M17 M
Gross Profit Margin (profit Margin After CGS)129 M9 M5 M5 M
Interest Expense Non Operating5 M5 M373000.029000.060000.056000.0
Interest Income Operating2 M5 M
Misc Other Special Charges528000.0-246000.02 M367000.02 M5 M6 M2 M2 M1 M
Net Income (loss)-85 M-276 M-228 M-340 M-307 M-291 M-231 M-119 M-79 M-57 M
Net Income Common Stockholders-85 M-276 M-228 M-340 M-307 M-291 M-231 M-119 M-79 M-57 M
Net Income Continuous Operations-85 M-276 M-228 M-340 M-307 M-291 M-231 M-119 M-79 M-57 M
Net Income Discontinuous Operations50 M
Net Non Operating Interest Income Expense-5 M-5 M-373000.0-29000.0-60000.0-56000.0
Normalized Income-80 M
Operating Income-83 M-276 M-281 M-340 M-309 M-296 M-237 M-122 M-81 M-58 M
Operating Income Before Depreciation (EBITDA)-76 M-266 M-223 M-331 M-301 M-284 M-227 M-119 M-79 M-57 M
Operating Expense191 M276 M344 M361 M309 M296 M-237 M-122 M-81 M-58 M
Other Gand A40 M51 M72 M79 M64 M80 M70 M40 M25 M17 M
Other Operating Expenses-2 M-6 M-8 M-28 M-25 M-23 M-13 M-16 M-5 M-3 M
Rent And Landing Fees70 M40 M25 M17 M
Research Expense151 M225 M273 M282 M245 M216 M167 M81 M57 M42 M
Restructring And Mn A Income5 M7 M6 M-49000.0
Salaries And Wages27 M45 M-64 M-20 M-34 M-23 M-17 M-10 M
Total Income Available For Interest Expense (EBIT)-81 M-271 M-228 M-340 M-309 M-291 M-231 M-120 M-79 M-57 M
Total Revenues129 M9 M
Total Expenses191 M276 M-344 M361 M309 M296 M-237 M-122 M81 M58 M
Total Revenue129 M9 M
Amord959000.0976000.0872000.0244000.0389000.0324000.0
Avgshs7 M4 M102 M4 M3 M2 M44 M30 M29 M26 M
Avgshsdt7 M4 M102 M4 M3 M2 M44 M30 M
Basiceps-11.41-65.25-2.24-90.75-103.75-141.75
Basicepscont-11.41-65.25-2.24-90.75-103.75-141.75
Cor21 M9 M-4 M-4 M
Depamor3 M4 M6 M9 M8 M7 M-4 M-956000.0-383000.0-48000.0
Dileps-11.41-65.25-2.24-90.75-103.75-141.75-5.27-4.0
Dilepscont-11.41-65.25-2.24
Netincdisc-85 M-276 M-228 M-340 M-307 M-291 M-231 M-119 M-79 M-57 M
Othincexp-528000.0246000.0-2 M-367000.0-2 M-5 M-6 M-2 M-2 M-1 M
Pretaxinc-85 M-276 M-228 M-340 M-307 M-291 M-231 M-120 M-79 M-57 M
Resdev151 M225 M273 M282 M245 M216 M167 M81 M57 M42 M
Restruct5 M7 M6 M-49000.0
Sga40 M51 M72 M79 M64 M80 M70 M40 M25 M17 M
Shsout6 M5 M96 M4 M3 M2 M46 M39 M29 M29 M
Specincchg-5 M-7 M-6 M49000.0
Taxprov-12000.015000.012000.046000.015000.012000.0-44000.0-14000.010000.0-9000.0